Target intelligence / Profile preview

RN7SK pseudogene 102 (RN7SKP102)

Target
RN7SKP102
Molecular classification
Other (Pseudogene)
01

Overview

RN7SK pseudogene 102 (RN7SKP102) is a non-functional, noncoding pseudogene related to the RN7SK small nuclear RNA gene (RN7SK). Pseudogenes like RN7SKP102 are generally considered genomic relics that do not produce active RNA or protein products. While the parental RN7SK gene plays a well-defined role in the regulation of transcription elongation through the 7SK small nuclear ribonucleoprotein complex, RN7SKP102 does not share these functions or have established biological or clinical relevance[5].

Other names
RN7SKP102

Beyond the preview

Go deeper on RN7SK pseudogene 102 (RN7SKP102).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RN7SK pseudogene 102 (RN7SKP102).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call